Morbus Crohn und Colitis ulcerosa: Neues vom ECCO-Jahreskongress – Rosenfluh.ch
Kurzmeldungen vom ECCO-Kongress 2018
NASA ECCO - Meeting Documents (Detail)
European Crohn´s and Colitis Organisation - ECCO - ECCO News
AW 2018 ECCO JOURNAL by Energy Plan Creative - Issuu
Tauseef Ali MD, FACG AGAF FACP on Twitter: "Sunday Review #IBD101 Withdrawal versus continuation of thiopurine in vedolizumab-treated patients with Ulcerative Colitis (VIEWS): a multi-centre randomised controlled trial https://t.co/KPVL2TcKX9" / Twitter
Accepted Manuscript
InDex Pharmaceuticals will participate in the Digestive Disease Week (DDW)
Ecco l'Uomo | Artwork | eazel
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease
European Crohn´s and Colitis Organisation - ECCO - Best epidemiological abstracts at ECCO'21
European Crohn´s and Colitis Organisation - ECCO - Volume 13, Issue 2
European Crohn´s and Colitis Organisation - ECCO - Volume 17, Issue 2
ESR News May 2018
PDF) 4th Congress of ECCO Inflammatory Bowel Diseases Impact of antiTNF treatment on Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: real world data in Germany
PDF) Young adults living with inflammatory bowel disease. A thematic synthesis of patient experience.
Abstract | Mathematics and Physics Education
PDF) DOP028 Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis
European Crohn´s and Colitis Organisation - ECCO - The 13th Congress of ECCO in numbers
Mathematics (Combinatorics) the Colombian Way: ECCO 2018
PDF) P232 Atherosclerosis in ulcerative colitis
European Crohn´s and Colitis Organisation - ECCO - Submit your congress abstract and share your research and clinical developments
